Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthesis and anti-HIV activity evaluation of novel N ′-arylidene-2-[1-(naphthalen-1-yl)-1 H -tetrazol-5-ylthio]acetohydrazides

Identifieur interne : 002C92 ( Main/Exploration ); précédent : 002C91; suivant : 002C93

Synthesis and anti-HIV activity evaluation of novel N ′-arylidene-2-[1-(naphthalen-1-yl)-1 H -tetrazol-5-ylthio]acetohydrazides

Auteurs : Peng Zhan [République populaire de Chine] ; Hongbing Liu [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] ; Yan Wang [République populaire de Chine] ; Christophe Pannecouque [Belgique] ; Myriam Witvrouw [Belgique] ; Erik De Clercq [Belgique]

Source :

RBID : ISTEX:55A5BEFD982BE6AC58F668CB35500CF60D434AC7

Descripteurs français

English descriptors

Abstract

Abstract: A series of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides was synthesized and evaluated, as nonnucleoside reverse transcriptase inhibitors (NNRTIs), for their in vitro HIV-1 and HIV-2 activity using the IIIB strain and ROD strain, respectively. The activity was monitored by the inhibition of the virus-induced cytopathic effect in the human T-lymphocyte (MT-4) cells. All of the new compounds were structurally confirmed by spectral analyses. Compounds 5q and 5r showed EC50 of 29.62 μM (CC50 of 169.24 ± 23.83μM) and 31.62 μM (CC50 > 309.06 μM), and resulting in selectivity index of 6 and >9, respectively. However, all newly synthesized derivatives were not active against HIV-2 replication. Graphical Abstract: A series of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides were synthesized and evaluated for their anti-HIV activities in MT-4 cell culture. Two compounds exhibited potent inhibitory activity specifically against HIV-1 replication.

Url:
DOI: 10.1007/s00044-009-9220-x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Synthesis and anti-HIV activity evaluation of novel N ′-arylidene-2-[1-(naphthalen-1-yl)-1 H -tetrazol-5-ylthio]acetohydrazides</title>
<author>
<name sortKey="Zhan, Peng" sort="Zhan, Peng" uniqKey="Zhan P" first="Peng" last="Zhan">Peng Zhan</name>
</author>
<author>
<name sortKey="Liu, Hongbing" sort="Liu, Hongbing" uniqKey="Liu H" first="Hongbing" last="Liu">Hongbing Liu</name>
</author>
<author>
<name sortKey="Liu, Xinyong" sort="Liu, Xinyong" uniqKey="Liu X" first="Xinyong" last="Liu">Xinyong Liu</name>
</author>
<author>
<name sortKey="Wang, Yan" sort="Wang, Yan" uniqKey="Wang Y" first="Yan" last="Wang">Yan Wang</name>
</author>
<author>
<name sortKey="Pannecouque, Christophe" sort="Pannecouque, Christophe" uniqKey="Pannecouque C" first="Christophe" last="Pannecouque">Christophe Pannecouque</name>
</author>
<author>
<name sortKey="Witvrouw, Myriam" sort="Witvrouw, Myriam" uniqKey="Witvrouw M" first="Myriam" last="Witvrouw">Myriam Witvrouw</name>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:55A5BEFD982BE6AC58F668CB35500CF60D434AC7</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1007/s00044-009-9220-x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-VLS8LPLD-S/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001930</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001930</idno>
<idno type="wicri:Area/Istex/Curation">001930</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C55</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C55</idno>
<idno type="wicri:doubleKey">1054-2523:2009:Zhan P:synthesis:and:anti</idno>
<idno type="wicri:Area/Main/Merge">002D46</idno>
<idno type="wicri:Area/Main/Curation">002C92</idno>
<idno type="wicri:Area/Main/Exploration">002C92</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Synthesis and anti-HIV activity evaluation of novel N ′-arylidene-2-[1-(naphthalen-1-yl)-1 H -tetrazol-5-ylthio]acetohydrazides</title>
<author>
<name sortKey="Zhan, Peng" sort="Zhan, Peng" uniqKey="Zhan P" first="Peng" last="Zhan">Peng Zhan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhuaxi Road, 250012, Jinan</wicri:regionArea>
<wicri:noRegion>Jinan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liu, Hongbing" sort="Liu, Hongbing" uniqKey="Liu H" first="Hongbing" last="Liu">Hongbing Liu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhuaxi Road, 250012, Jinan</wicri:regionArea>
<wicri:noRegion>Jinan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Liu, Xinyong" sort="Liu, Xinyong" uniqKey="Liu X" first="Xinyong" last="Liu">Xinyong Liu</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhuaxi Road, 250012, Jinan</wicri:regionArea>
<wicri:noRegion>Jinan</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Wang, Yan" sort="Wang, Yan" uniqKey="Wang Y" first="Yan" last="Wang">Yan Wang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhuaxi Road, 250012, Jinan</wicri:regionArea>
<wicri:noRegion>Jinan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pannecouque, Christophe" sort="Pannecouque, Christophe" uniqKey="Pannecouque C" first="Christophe" last="Pannecouque">Christophe Pannecouque</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000, Leuven</wicri:regionArea>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
<placeName>
<settlement type="city">Louvain</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province du Brabant flamand</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Witvrouw, Myriam" sort="Witvrouw, Myriam" uniqKey="Witvrouw M" first="Myriam" last="Witvrouw">Myriam Witvrouw</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000, Leuven</wicri:regionArea>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
<placeName>
<settlement type="city">Louvain</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province du Brabant flamand</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000, Leuven</wicri:regionArea>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
<placeName>
<settlement type="city">Louvain</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province du Brabant flamand</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Medicinal Chemistry Research</title>
<title level="j" type="abbrev">Med Chem Res</title>
<idno type="ISSN">1054-2523</idno>
<idno type="eISSN">1554-8120</idno>
<imprint>
<publisher>SP Birkhäuser Verlag Boston</publisher>
<pubPlace>Boston</pubPlace>
<date type="published" when="2010-09-01">2010-09-01</date>
<biblScope unit="volume">19</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="652">652</biblScope>
<biblScope unit="page" to="663">663</biblScope>
</imprint>
<idno type="ISSN">1054-2523</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1054-2523</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>AIDS</term>
<term>Acetohydrazides</term>
<term>Antiviral activity</term>
<term>HIV-1</term>
<term>NNRTIs</term>
<term>Tetrazole</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Sida</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: A series of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides was synthesized and evaluated, as nonnucleoside reverse transcriptase inhibitors (NNRTIs), for their in vitro HIV-1 and HIV-2 activity using the IIIB strain and ROD strain, respectively. The activity was monitored by the inhibition of the virus-induced cytopathic effect in the human T-lymphocyte (MT-4) cells. All of the new compounds were structurally confirmed by spectral analyses. Compounds 5q and 5r showed EC50 of 29.62 μM (CC50 of 169.24 ± 23.83μM) and 31.62 μM (CC50 > 309.06 μM), and resulting in selectivity index of 6 and >9, respectively. However, all newly synthesized derivatives were not active against HIV-2 replication. Graphical Abstract: A series of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides were synthesized and evaluated for their anti-HIV activities in MT-4 cell culture. Two compounds exhibited potent inhibitory activity specifically against HIV-1 replication.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Belgique</li>
<li>République populaire de Chine</li>
</country>
<region>
<li>Province du Brabant flamand</li>
<li>Région flamande</li>
</region>
<settlement>
<li>Louvain</li>
</settlement>
<orgName>
<li>Katholieke Universiteit Leuven</li>
</orgName>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Zhan, Peng" sort="Zhan, Peng" uniqKey="Zhan P" first="Peng" last="Zhan">Peng Zhan</name>
</noRegion>
<name sortKey="Liu, Hongbing" sort="Liu, Hongbing" uniqKey="Liu H" first="Hongbing" last="Liu">Hongbing Liu</name>
<name sortKey="Liu, Xinyong" sort="Liu, Xinyong" uniqKey="Liu X" first="Xinyong" last="Liu">Xinyong Liu</name>
<name sortKey="Liu, Xinyong" sort="Liu, Xinyong" uniqKey="Liu X" first="Xinyong" last="Liu">Xinyong Liu</name>
<name sortKey="Wang, Yan" sort="Wang, Yan" uniqKey="Wang Y" first="Yan" last="Wang">Yan Wang</name>
</country>
<country name="Belgique">
<region name="Région flamande">
<name sortKey="Pannecouque, Christophe" sort="Pannecouque, Christophe" uniqKey="Pannecouque C" first="Christophe" last="Pannecouque">Christophe Pannecouque</name>
</region>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<name sortKey="Witvrouw, Myriam" sort="Witvrouw, Myriam" uniqKey="Witvrouw M" first="Myriam" last="Witvrouw">Myriam Witvrouw</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C92 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C92 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:55A5BEFD982BE6AC58F668CB35500CF60D434AC7
   |texte=   Synthesis and anti-HIV activity evaluation of novel N ′-arylidene-2-[1-(naphthalen-1-yl)-1 H -tetrazol-5-ylthio]acetohydrazides
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021